Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications
- 1 August 2000
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 39 (2) , 127-153
- https://doi.org/10.2165/00003088-200039020-00004
Abstract
Caffeine from dietary sources (mainly coffee, tea and soft drinks) is the most frequently and widely consumed CNS stimulant in the world today. Because of its enormous popularity, the consumption of...Keywords
This publication has 220 references indexed in Scilit:
- Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophyllineBritish Journal of Clinical Pharmacology, 1999
- Five Distinct Human Cytochromes Mediate Amitriptyline N‐Demethylation In Vitro: Dominance of CYP 2C19 and 3A4The Journal of Clinical Pharmacology, 1998
- The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapineBritish Journal of Clinical Pharmacology, 1997
- Regulation of Dioxin Receptor Function by OmeprazolePublished by Elsevier ,1997
- CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeineBritish Journal of Clinical Pharmacology, 1996
- Ofloxacin Clinical PharmacokineticsClinical Pharmacokinetics, 1992
- Effects of Temafloxacin and Ciprofloxacin on the Pharmacokinetics of Caffeine†Clinical Pharmacokinetics, 1992
- Verapamil‐Induced Inhibition of Theophylline Elimination in Healthy HumansBasic & Clinical Pharmacology & Toxicology, 1990
- Interaction Between Quinolones and CaffeineDrugs, 1987
- Plasma Level Monitoring of Antipsychotic Drugs Clinical UtilityClinical Pharmacokinetics, 1986